Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Solesence (SLSN) Research & Development (2016 - 2025)

Solesence's Research & Development history spans 16 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Research & Development fell 5.13% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $4.1 million, up 6.65%, while the annual FY2025 figure was $4.1 million, 6.59% up from the prior year.
  • Research & Development reached $1.0 million in Q4 2025 per SLSN's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.1 million in Q4 2024 to a low of $499000.0 in Q1 2021.
  • Average Research & Development over 5 years is $851700.0, with a median of $887000.0 recorded in 2024.
  • The largest YoY upside for Research & Development was 56.79% in 2021 against a maximum downside of 59.9% in 2021.
  • A 5-year view of Research & Development shows it stood at $565000.0 in 2021, then grew by 28.67% to $727000.0 in 2022, then grew by 7.98% to $785000.0 in 2023, then skyrocketed by 38.98% to $1.1 million in 2024, then dropped by 5.13% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Research & Development are $1.0 million (Q4 2025), $1.1 million (Q3 2025), and $955000.0 (Q2 2025).